AFreeze

AFreeze is an Austrian medical device company focused on treating cardiac arrhythmias, particularly atrial fibrillation. The company has developed a proprietary cryotechnology-based ablation platform, including the CoolLoop cryoablation catheter/system, designed to create precise lesions in cardiac tissue during electrophysiology procedures. Public company descriptions indicate that AFreeze has obtained regulatory approval for its patented cryo-ablation catheter and is positioning the product for use in the growing atrial fibrillation ablation market. The business appears to be a private, active medtech company rather than a therapeutics biotech developer. Its core value proposition is improving physician workflow and patient outcomes in cardiac rhythm management through device innovation.